From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors

Aromatase inhibitors (AI) are extensively used as adjuvant endocrine therapy in post-menopausal women with hormone receptor-positive early breast cancer (HR+ EBC), but their impact on bone health is not negligible. This work aimed to assess bone loss, fracture incidence, and risk factors associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasconcelos de Matos, Leonor, Fernandes, Leonor, Neves, Maria Teresa, Alves, Fátima, Baleiras, Mafalda, Ferreira, André, Giesteira Cotovio, Pedro, Dias Domingues, Tiago, Malheiro, Mariana, Plácido, Ana, Miranda, Maria Helena, Martins, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025750/
https://www.ncbi.nlm.nih.gov/pubmed/33652975
http://dx.doi.org/10.3390/curroncol28020104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025750/
https://www.ncbi.nlm.nih.gov/pubmed/33652975
http://dx.doi.org/10.3390/curroncol28020104

Ejemplares similares